A small-molecule TLR4 antagonist reduced neuroinflammation in female E4FAD mice

Abstract

Background APOE genotype is the greatest genetic risk factor for sporadic Alzheimer’s disease (AD). APOE4 increases AD risk up to 12-fold compared to APOE3, an effect that is greater in females. Evidence suggests that one-way APOE could modulate AD risk and progression through neuroinflammation. Indeed, APOE4 is associated with higher glial activation and cytokine levels in AD patients and mice. Therefore, identifying pathways that contribute to APOE4-associated neuroinflammation is an important approach for understanding and treating AD. Human and in vivo evidence suggests that TLR4, one of the key receptors involved in the innate immune system, could be involved in APOE-modulated neuroinflammation. Consistent with that idea, we previously demonstrated that the TLR4 antagonist IAXO-101 can reduce LPS- and Aβ-induced cytokine secretion in APOE4 glial cultures. Therefore, the goal of this study was to advance these findings and determine whether IAXO-101 can modulate neuroinflammation, Aβ pathology, and behavior in mice that express APOE4. Methods We used mice that express five familial AD mutations and human APOE3 (E3FAD) or APOE4 (E4FAD). Female and male E4FAD mice and female E3FAD mice were treated with vehicle or IAXO-101 in two treatment paradigms: prevention from 4 to 6 months of age or reversal from 6 to 7 months of age. Learning and memory were assessed by modified Morris water maze. Aβ deposition, fibrillar amyloid deposition, astrogliosis, and microgliosis were assessed by immunohistochemistry. Soluble levels of Aβ and apoE, insoluble levels of apoE and Aβ, and IL-1β were measured by ELISA. Results IAXO-101 treatment resulted in lower Iba-1 coverage, lower number of reactive microglia, and improved memory in female E4FAD mice in both prevention and reversal paradigms. IAXO-101-treated male E4FAD mice also had lower Iba-1 coverage and reactivity in the RVS paradigm, but there was no effect on behavior. There was also no effect of IAXO-101 treatment on neuroinflammation and behavior in female E3FAD mice. Conclusion Our data supports that TLR4 is a potential mechanistic therapeutic target for modulating neuroinflammation and cognition in APOE4 females.

Estradiol improves behavior in FAD transgenic mice that express APOE3 but not APOE4 after ovariectomy

“…Uterine horns were dissected from the mice and weighed. Then, the brains were removed and harvested for biochemical and immunohistochemical analysis as described previously ( 36 , 37 ). For biochemical analysis, the cortex was dissected from the hemi-brain, flash-frozen in liquid nitrogen, and then stored at -80°C.…”

Enantiomer-Dependent Supramolecular Immunosuppressive Modulation for Tissue Reconstruction

“…The homeostasis of immune cells in chiral environments greatly impacts the progression of diseases . Although the apparent chiral preference for extracellular matrix (ECM) under physiological or pathological conditions is a crucial extracellular environmental parameter, − little is known about how this chiral signaling manipulates the immune response. Therefore, discovering chiral biomaterials and understanding their corresponding immune effects may contribute to advancements in the mechanisms underlying the progression of wound healing.…”